Looking back over the past 12 months, Information Technology was heads and shoulders the best-performing sector.

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and ...

Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that ...

24 Dec 2024 - S&P 500 and Nasdaq climb despite weak economic data, as investors eye a potential Santa rally.

Mesoblast specialises in developing medicines that treat severe inflammatory conditions. Their technology is being applied to conditions like chronic heart failure and chronic low back pain.

Larvotto Resources (ASX:LRV) has reported final results from its reverse circulation drilling program at the Clarks Gully deposit, which is part of the company's Hillgrove Gold-Antimony Project in ...

This week saw a flurry of activity in the small-cap market, with exciting developments in biotech, energy, and litigation funding. Here’s a snapshot of the stocks making headlines. INOVIQ (ASX ...

Global shares were mixed over the last week with a back up in bond yields and a bit of profit taking after a strong run up weighing on US and Eurozone shares leading to small falls. Chinese shares ...

Silex Systems (ASX:SLX) specialises in laser-based technology for uranium enrichment. Its proprietary SILEX (Separation of Isotopes by Laser Excitation) process uses lasers to selectively excite ...

Rio Tinto (ASX:RIO) plans to invest $2.5bn at its Rincon lithium project in Argentina. The aim is to lift production capacity at Rincon to 60,000 tonnes of battery-grade lithium carbonate per year.

US stocks struggled last week as concerns over inflation and US president-elect Donald Trump’s tariff plans weighed on sentiment. The Dow slipped 0.2%, the S&P 500 was flat, and the Nasdaq ...

INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and more than 90% sensitivity, a promising advance for early detection.